Posts by Sydney B. Montesi, MD
-
Review: Managing Lung Cancer in Patients With Interstitial Lung Disease
Massachusetts General Hospital researchers recently summarized evidence about the risk of lung cancer in patients with interstitial lung disease (ILD), considerations for diagnosis and treatment of lung cancer in that population, and monitoring for ILD progression during lung cancer treatment.
-
Translational Research in Radiology: the Clinical Potential of Molecular Imaging of Pulmonary Fibrosis
Peter Caravan, PhD, and Sydney Montesi, MD, discuss the potential of molecular imaging of pulmonary fibrosis for managing patients with interstitial lung disease and other clinical applications.
-
Multicenter Study: Rituximab Promising for Interstitial Pneumonia with Autoimmune Features
In a retrospective study, researchers at Massachusetts General Hospital and University of Chicago Medicine found that the majority of patients with interstitial pneumonia with autoimmune features treated with rituximab had clinical improvement or stability, with few adverse events.
-
Pembrolizumab and Nivolumab Not Linked to Increased Mortality in Cancer Patients with Interstitial Lung Disease
Although a thorough risk–benefit analysis is necessary, PD-1 inhibitors should not be uniformly withheld from cancer patients who have underlying interstitial lung disease, according to a study by Sydney B. Montesi, MD, and Amita Sharma, MBBS, clinician-researchers at Massachusetts General Hospital, and colleagues.
-
New Molecular Imaging Tool Detects Pulmonary Fibrosis
Massachusetts General Hospital researchers use novel PET probe to find type I collagen and identify disease activity in pulmonary fibrosis.
Biography
Dr. Montesi received her medical degree from the University of Rochester School of Medicine and Dentistry. She then completed her residency in internal medicine at Massachusetts General Hospital and her fellowship in pulmonary and critical care medicine at the Harvard Combined Program. She is currently on staff in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital. She specializes in the care of patients with interstitial lung diseases. She also does translational and clinical research in the area of pulmonary fibrosis.
Pulmonary and Critical Care Medicine
The Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital provides comprehensive care for the full range of respiratory conditions and diseases.